The cover story in the Dec. 25, 2018, issue of Ocular Surgery News focused on the FDA approval process for ophthalmology in 2018.
Here are some of the issue’s publication exclusives:
Cover Story
Improved communication evident in FDA approval process for 2018
More meaningful endpoints for clinical trials, better communication for necessary study designs and an improved approval process have led to more efficient FDA approvals for ophthalmologic drugs and devices in 2018. Read more.
Lindstrom’s Perspective
Future looks optimistic for ophthalmology
Thanks to the efforts of Wiley
Uncategorized